Oprah reveals diabetes drug role in her weight loss journey
Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she revealed that this process helped her understand slim people. Oprah Winfrey has struggled with weight issues for years.
Hollywood's use of Ozempic as 'weight loss drug' sees surge in public use
EXCLUSIVE: Hollywood's Ozempic use has been steadily rising with many celebrities crediting the drug for their weight loss, which has seen the public keen to do the same.
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.
Benefits and risks of popular weight-loss drugs revealed
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes,
Amy Schumer Reveals Why She Quit Ozempic Despite Dropping 30 Pounds From the Weight-Loss Drug
Amy Schumer got brutally honest about the pros and cons she experienced while taking popular weight-loss drug Ozempic. On the Wednesday, January 29, installment of The Howard Stern Show, the actress revealed she took the medication "almost three years ago.
Amy Schumer Lost 30 Lbs. on Ozempic — 'I Looked Great' — but Quit After Being ‘Bedridden’ with Nausea
Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the medication after the weekly injections gave her bad nausea that left her bedridden.
Amy Schumer Details 'Horrible Experience' Using Ozempic for Weight Loss
Once upon a time, Amy Schumer was one of the countless stars falling in line for the Ozempic craze, but, despite losing 30 pounds with the help of the Type 2 diabetes drug, the comedian had an overall "horrible experience" with it.
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
HealthDay on MSN9d
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular weight loss drugs could be cheaper for some Americans: What you need to know
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
Burlington biotech slims down 17% of workforce, focuses on weight maintenance treatment
Fractyl Health plans to slim down by 17% of its workforce as it focus on weight maintenance for those coming off of GLP-1 drugs.
The Lancet6d
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...